Analysis of Liquidity Ratios
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
UnitedHealth Group Inc., liquidity ratios
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Current ratio | 0.79 | 0.83 | 0.79 | 0.77 | 0.79 | |
| Quick ratio | 0.70 | 0.75 | 0.73 | 0.70 | 0.72 | |
| Cash ratio | 0.24 | 0.28 | 0.34 | 0.36 | 0.36 |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The liquidity position, as indicated by the observed ratios, demonstrates a generally stable but subtly shifting trend over the five-year period. While the current and quick ratios exhibit relative consistency, the cash ratio reveals a noticeable decline. Overall, the company maintains a short-term asset base that covers its immediate liabilities, but the composition of those assets is evolving.
- Current Ratio
- The current ratio remained relatively flat between 2021 and 2025, fluctuating between 0.77 and 0.83. It began at 0.79 in 2021, decreased slightly to 0.77 in 2022, recovered to 0.79 in 2023, increased to 0.83 in 2024, and then returned to 0.79 in 2025. This suggests a consistent ability to cover short-term liabilities with short-term assets, with minimal variation over the period.
- Quick Ratio
- Similar to the current ratio, the quick ratio exhibited a stable pattern. Starting at 0.72 in 2021, it decreased to 0.70 in 2022, then increased to 0.73 in 2023 and 0.75 in 2024 before declining to 0.70 in 2025. The quick ratio’s consistency indicates a reliable capacity to meet short-term obligations with the most liquid assets, excluding inventory.
- Cash Ratio
- A clear downward trend is observed in the cash ratio. Beginning at 0.36 in both 2021 and 2022, it decreased to 0.34 in 2023, then to 0.28 in 2024, and further to 0.24 in 2025. This indicates a decreasing proportion of current assets held as cash, potentially suggesting a shift towards other, less liquid, short-term investments or increased deployment of cash into operations. While still representing a portion of immediate liabilities, the company’s reliance on cash to cover these obligations is diminishing.
In summary, the company demonstrates a consistent short-term solvency position based on the current and quick ratios. However, the declining cash ratio warrants further investigation to understand the underlying reasons for the shift in asset allocation and its potential implications for short-term financial flexibility.
AI Ask an analyst for more
Current Ratio
UnitedHealth Group Inc., current ratio calculation, comparison to benchmarks
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Current assets | 90,582) | 85,779) | 78,437) | 69,069) | 61,758) | |
| Current liabilities | 114,897) | 103,769) | 99,054) | 89,237) | 78,292) | |
| Liquidity Ratio | ||||||
| Current ratio1 | 0.79 | 0.83 | 0.79 | 0.77 | 0.79 | |
| Benchmarks | ||||||
| Current Ratio, Competitors2 | ||||||
| Abbott Laboratories | 1.58 | 1.67 | 1.64 | 1.63 | 1.85 | |
| Elevance Health Inc. | 1.54 | 1.45 | 1.44 | 1.40 | 1.47 | |
| Intuitive Surgical Inc. | 4.87 | 4.07 | 4.76 | 4.40 | 5.08 | |
| Medtronic PLC | 1.85 | 2.03 | 2.39 | 1.86 | 2.65 | |
| Current Ratio, Sector | ||||||
| Health Care Equipment & Services | 1.14 | 1.15 | 1.15 | 1.13 | 1.22 | |
| Current Ratio, Industry | ||||||
| Health Care | 1.23 | 1.21 | 1.23 | 1.23 | 1.31 | |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= 90,582 ÷ 114,897 = 0.79
2 Click competitor name to see calculations.
The current ratio exhibits a relatively stable pattern over the five-year period, fluctuating within a narrow range. While there are some year-to-year changes, no strong upward or downward trend is apparent.
- Current Ratio Trend
- The current ratio began at 0.79 in 2021. It decreased slightly to 0.77 in 2022 before recovering to 0.79 in 2023. A modest increase was observed in 2024, reaching 0.83, but it subsequently declined to 0.79 in 2025, returning to the level observed in 2021 and 2023.
The observed fluctuations suggest a consistent, but not dramatically changing, ability to cover short-term liabilities with short-term assets. The ratio consistently remains below 1, indicating that current liabilities exceed current assets in each year examined. This suggests a reliance on asset conversion or financing to meet immediate obligations.
- Relationship to Underlying Components
- Current assets increased steadily throughout the period, growing from US$61,758 million in 2021 to US$90,582 million in 2025. However, current liabilities experienced a more substantial increase, rising from US$78,292 million in 2021 to US$114,897 million in 2025. The faster growth of liabilities relative to assets explains the limited movement in the current ratio.
The slight improvement in the current ratio in 2024 was likely driven by a slower growth rate in current liabilities compared to current assets. However, this improvement was not sustained, as the ratio reverted to its previous level in 2025. Overall, the current ratio demonstrates a consistent, though somewhat constrained, liquidity position.
AI Ask an analyst for more
Quick Ratio
UnitedHealth Group Inc., quick ratio calculation, comparison to benchmarks
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Cash and cash equivalents | 24,365) | 25,312) | 25,427) | 23,365) | 21,375) | |
| Short-term investments | 3,756) | 3,801) | 4,201) | 4,546) | 2,532) | |
| Accounts receivable, net of allowances | 23,018) | 22,365) | 21,276) | 17,681) | 14,216) | |
| Other current receivables, net of allowances | 29,697) | 26,089) | 17,694) | 12,769) | 13,866) | |
| Assets under management | —) | —) | 3,755) | 4,087) | 4,449) | |
| Total quick assets | 80,836) | 77,567) | 72,353) | 62,448) | 56,438) | |
| Current liabilities | 114,897) | 103,769) | 99,054) | 89,237) | 78,292) | |
| Liquidity Ratio | ||||||
| Quick ratio1 | 0.70 | 0.75 | 0.73 | 0.70 | 0.72 | |
| Benchmarks | ||||||
| Quick Ratio, Competitors2 | ||||||
| Abbott Laboratories | 1.02 | 1.05 | 1.00 | 1.06 | 1.28 | |
| Elevance Health Inc. | 1.41 | 1.32 | 1.30 | 1.27 | 1.33 | |
| Intuitive Surgical Inc. | 3.72 | 3.00 | 3.83 | 3.56 | 4.34 | |
| Medtronic PLC | 1.20 | 1.31 | 1.54 | 1.30 | 1.91 | |
| Quick Ratio, Sector | ||||||
| Health Care Equipment & Services | 0.95 | 0.97 | 0.97 | 0.95 | 1.04 | |
| Quick Ratio, Industry | ||||||
| Health Care | 0.88 | 0.88 | 0.90 | 0.93 | 1.00 | |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 80,836 ÷ 114,897 = 0.70
2 Click competitor name to see calculations.
The quick ratio exhibited a fluctuating pattern over the five-year period. While generally remaining within a narrow range, subtle shifts are observable. Total quick assets demonstrated consistent growth throughout the period, while current liabilities increased at a faster rate initially, then moderated.
- Quick Ratio Trend
- The quick ratio began at 0.72 in 2021, decreased slightly to 0.70 in 2022, and then recovered to 0.73 in 2023. A further increase to 0.75 was noted in 2024, followed by a decline to 0.70 in 2025. This suggests a moderate level of short-term liquidity that experienced some volatility.
- Asset and Liability Dynamics
- Total quick assets increased from US$56,438 million in 2021 to US$80,836 million in 2025, representing a substantial overall increase. However, current liabilities grew from US$78,292 million in 2021 to US$114,897 million in 2025. The initial faster growth of liabilities compared to assets contributed to the dip in the quick ratio in 2022. The subsequent moderation in liability growth allowed the quick ratio to improve in 2023 and 2024, but renewed growth in liabilities in 2025 led to a decrease.
The observed fluctuations in the quick ratio, despite the overall growth in quick assets, indicate that the company’s ability to meet its immediate obligations with its most liquid assets is sensitive to changes in current liabilities. The ratio remained below one throughout the period, suggesting the company does not have a dollar of quick assets for every dollar of current liabilities.
AI Ask an analyst for more
Cash Ratio
UnitedHealth Group Inc., cash ratio calculation, comparison to benchmarks
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Cash and cash equivalents | 24,365) | 25,312) | 25,427) | 23,365) | 21,375) | |
| Short-term investments | 3,756) | 3,801) | 4,201) | 4,546) | 2,532) | |
| Assets under management | —) | —) | 3,755) | 4,087) | 4,449) | |
| Total cash assets | 28,121) | 29,113) | 33,383) | 31,998) | 28,356) | |
| Current liabilities | 114,897) | 103,769) | 99,054) | 89,237) | 78,292) | |
| Liquidity Ratio | ||||||
| Cash ratio1 | 0.24 | 0.28 | 0.34 | 0.36 | 0.36 | |
| Benchmarks | ||||||
| Cash Ratio, Competitors2 | ||||||
| Abbott Laboratories | 0.54 | 0.56 | 0.53 | 0.66 | 0.78 | |
| Elevance Health Inc. | 0.88 | 0.85 | 0.87 | 0.86 | 0.95 | |
| Intuitive Surgical Inc. | 2.96 | 2.30 | 3.15 | 2.90 | 3.66 | |
| Medtronic PLC | 0.70 | 0.74 | 0.88 | 0.85 | 1.27 | |
| Cash Ratio, Sector | ||||||
| Health Care Equipment & Services | 0.47 | 0.49 | 0.55 | 0.58 | 0.64 | |
| Cash Ratio, Industry | ||||||
| Health Care | 0.43 | 0.46 | 0.50 | 0.54 | 0.60 | |
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 28,121 ÷ 114,897 = 0.24
2 Click competitor name to see calculations.
The cash ratio exhibited a consistent, albeit gradual, decline over the five-year period examined. While total cash assets increased initially, the growth in current liabilities outpaced this increase, resulting in a decreasing ability to cover short-term obligations with only cash and cash equivalents.
- Cash Ratio Trend
- The cash ratio remained relatively stable at 0.36 in both 2021 and 2022. A slight decrease to 0.34 was observed in 2023. This decline accelerated in 2024, with the ratio falling to 0.28, and continued into 2025, reaching 0.24. This represents a cumulative decrease of 33.3% from 2021 to 2025.
- Cash Assets
- Total cash assets increased from US$28,356 million in 2021 to US$33,383 million in 2023, representing a peak in the observed period. However, cash assets then decreased in subsequent years, falling to US$29,113 million in 2024 and further to US$28,121 million in 2025. This suggests a potential shift in asset allocation or increased investment in other areas.
- Current Liabilities
- Current liabilities demonstrated a consistent upward trend throughout the period. From US$78,292 million in 2021, they increased to US$89,237 million in 2022, US$99,054 million in 2023, US$103,769 million in 2024, and reached US$114,897 million in 2025. This continuous growth in short-term obligations is the primary driver of the declining cash ratio.
The observed trend suggests a growing reliance on sources other than immediately available cash to meet short-term obligations. While not necessarily indicative of immediate financial distress, the decreasing cash ratio warrants further investigation into the composition of current liabilities and the company’s overall liquidity management strategy.
AI Ask an analyst for more